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GENERAL COMMENTS
This paper analysis the use of new ACR/EULAR criteria (with particular focus on specificity) in rheumatology outpatients seen in routine care. This study adds to the recent literature on classification criteria for RA by showing that the new criteria have a relatively lower specificity compared to the 1987 criteria.
While the validity of the new RA criteria has been tested in various cohorts, testing the criteria among consecutive patients seen in routine care is certainly a good idea as well as a necessary exercise.
The paper is carefully and beautifully written. (The only, and really minor, suggestion I have is to place a dot between arthritis and Almost in page 11, line 22).
Although it doesn't change the importance of the study, the statement " We believe this is the first study to examine the new 2010 …………" (page 11, line 6) seems to be improper considering the previous study by 
THE STUDY
With regard to how representative the patients are, this population is of new and return patients. It is acknowleged that the later criteria are aimed at earlier diagnosis so the populations should probably be sepatated so that we may assess how the criteria perform in the different populations,
GENERAL COMMENTS
This is an interesting investigation of the criteria described. It shows them to be more sensitive but less specific than the previous ones. As above I would like to see the data separated for new and review patients. It is acknowleged that this sensitivity may be appropriate for early referral from primary care. Do they have any suggestions from the data that would indicate which items are leading to the lack of specifity. They make the interesting point that "if you have eliminated all other possible diagnoses then you must have RA! It is interesting that the SLE and PSA criteria function better. Do they have an explanation for this? There is a typographical error in the intro. "of" should be "off" THE STUDY Kennish et al. described the utility of the new criteria for rheumatoid arthritis in real world. This thesis is very important and interesting, but this current study has some limitations. First of all, the chronology of the time when the criteria were applied to subjects and the time of diagnosis and the time of analysis was unclear. If the criteria were applied at the patient's first visit to the hospital before the treatment was started, isn't this study retrospective? If this was prospective as described in the first page, the fact that the subjects included the patients who had been already treated with DMARDs, steroid and biologic agents had perhaps great impact on the condition of patients, including the number of joints, the value of CRP/ESR and even possibly titer of RF/anti-CCP. And the number of subjects was too small. Moreover more than 10% of patients were excluded from analysis due to insufficient data, but those might have different characteristics from those analyzed, which could influence the sensitivity and specificity. RESULTS & CONCLUSIONS The analysis of the data and interpretation of results were perhaps correct, but in the first place the subject group analyzed appears inappropriate. While the validity of the new RA criteria has been tested in various cohorts, testing the criteria among consecutive patients seen in routine care is certainly a good idea as well as a necessary exercise.
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Although it doesn't change the importance of the study, the statement " We believe this is the first study to examine the new 2010 …………" (page 11, line 6) seems to be improper considering the previous study by With regard to how representative the patients are, this population is of new and return patients. It is acknowleged that the later criteria are aimed at earlier diagnosis so the populations should probably be sepatated so that we may assess how the criteria perform in the different populations, This is an interesting investigation of the criteria described. It shows them to be more sensitive but less specific than the previous ones. As above I would like to see the data separated for new and review patients. It is acknowleged that this sensitivity may be appropriate for early referral from primary care. Do they have any suggestions from the data that would indicate which items are leading to the lack of specifity. They make the interesting point that "if you have eliminated all other possible diagnoses then you must have RA! It is interesting that the SLE and PSA criteria function better. Do they have an explanation for this? There is a typographical error in the intro. "of" should be "off" Authors' response: We thank the reviewer for his comments. We have corrected the typo. Most of the patients were not new patients (new=28) and two of those were RA patients hence we were not able to analyse the small numbers of patients separately. However as we discuss in our paper, we were trying to see how the new criteria would perform in an "all comers" setting to differentiate patients. As most classification criteria are also used as diagnostic criteria, we wanted to highlight the possible problems that may arise from the use of new RA criteria.
Even though we did not separately study which portions of the criteria are leading to low specificity , dependence on laboratory testing may likely be responsible as a lot of other inflammatory conditions have elevated antibody and inflammation markers, along with joint involvement.
Reviewer: Yuko Kaneko Assisstant Professor Keio Univeristy School of Medicine, Department of Internal Medicine, Division of Rheumatology Japan Competimg interests: none Kennish et al. described the utility of the new criteria for rheumatoid arthritis in real world. This thesis is very important and interesting, but this current study has some limitations. First of all, the chronology of the time when the criteria were applied to subjects and the time of diagnosis and the time of analysis was unclear. If the criteria were applied at the patient's first visit to the hospital before the treatment was started, isn't this study retrospective? If this was prospective as described in the first page, the fact that the subjects included the patients who had been already treated with DMARDs, steroid and biologic agents had perhaps great impact on the condition of patients, including the number of joints, the value of CRP/ESR and even possibly titer of RF/anti-CCP. And the number of subjects was too small. Moreover more than 10% of patients were excluded from analysis due to insufficient data, but those might have different characteristics from those analyzed, which could influence the sensitivity and specificity.
The analysis of the data and interpretation of results were perhaps correct, but in the first place the subject group analyzed appears inappropriate.
